Closing the Brief Case: A Reactive HIV Rapid Antibody Test in a
Pregnant Woman (See page 826 in this issue [doi:10.1128/JCM.02647-15] for case presentation and discussion.)
Melanie L. Yarbrough, Neil W. Anderson
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
ANSWERS TO SELF-ASSESSMENT QUESTIONS (a) An earlier time to positivity following infection.
(b) The ability to distinguish HIV-1 antibodies from 1. After a positive HIV rapid antibody test, which of the fol- HIV-2 antibodies. lowing tests should be ordered next? (c) The ability to rule out HIV infection based on a (a) HIV-1 Western blot assay. negative result. (b) HIV-1 nucleic acid amplification test. (d) A faster turnaround time. (c) HIV antigen/antibody immunoassay. Answer: c. HIV-1/2 differentiation has an earlier time to (d) HIV-1/2 differentiation assay. positivity, faster turnaround time, and lower cost than Answer: c. According to the 2014 CDC recommendations HIV-1 Western blotting. Negative results still require con- for the diagnostic testing of HIV, patients with positive firmation with a molecular test to rule out acute HIV. rapid antibody assay results should be tested by the fourth- generation algorithm in its entirety. Therefore, the most TAKE-HOME POINTS appropriate next test is the HIV antigen/antibody immuno- • Compared to third-generation antibody assays, fourth-gen- assay. eration antigen/antibody assays are more sensitive, more specific, and capable of earlier detection of HIV infection. 2. In a low-risk patient, which of the following results require confirmatory testing with a qualitative molecular assay for • Testing for HIV by the fourth-generation algorithm entails HIV-1 as the next step? screening with an antigen/antibody assay and confirmatory testing with an HIV-1/2 differentiation assay. (a) HIV antigen/antibody immunoassay positive and HIV-1/2 differentiation assay negative. • Patients with a reactive antigen/antibody assay but nonreac- tive HIV-1/2 differentiation assay should have molecular (b) HIV antigen/antibody immunoassay positive and testing performed to distinguish acute HIV infection from a HIV-1/2 differentiation assay positive. false-positive screen result. (c) HIV rapid antibody test positive and HIV antigen/ • Rapid HIV antibody tests offer a quick turnaround time, but antibody immunoassay negative.
Downloaded from https://journals.asm.org/journal/jcm on 09 March 2023 by 165.225.125.35.
1 Clinical Evaluation of BioPlex 2200 HIV AgAb, An Automated Screening Method Providing Discrete Detection of HIV1 p24 Antigen, HIV1 Antibody, and HIV2 Antibody.
Diagnostic Performance of Xpert MTB, RIF Ultra Compared With Predecessor Test, Xpert MTB RIF, in A Low TB Incidence Setting A Retrospective Service Evaluation